Literature DB >> 3659613

Tuberculostearic acid in lymph nodes from patients with sarcoidosis.

A Hanngren1, G Odham, A Eklund, S Hoffner, N Stjernberg, G Westerdahl.   

Abstract

It has earlier been suggested that mycobacteria may play an aetiological role in the development of sarcoidosis. To investigate this further we analyzed the presence of a characteristic mycobacterial constituent, tuberculostearic acid (TS, 10-methyloctadecanoic acid), in lymph nodes from 22 patients with sarcoidosis and in eleven children and three adult controls. To detect TS gas chromatography/mass spectrometry was used. These findings were compared with the results from conventional mycobacterial culture and radiometric respirometry. Although the latter techniques failed to detect mycobacteria in all the tested tissue samples, TS was found in various amounts. Thus, 0-3 micrograms TS/g freeze-dried tissue was noted in eight sarcoid patients, 3-50 micrograms TS/g in eight and 51-400 micrograms TS/g in the remaining six patients. Among the controls only 1/14 had detectable TS. In one patient with lymph node tuberculosis TS was in the range 51-400 micrograms/g. We conclude that the findings could be explained by the presence of mycobacteria not cultivable with the studied techniques or with the presence of remnants after an earlier colonisation with mycobacteria, e.g. BCG-vaccination. Mycobacteria or mycobacterial cell-envelope in sarcoid tissue may possibly act as cofactors in the development of the disease, i.e. they might function as triggering agents (adjuvans) of the immune response. On the other hand the findings may be without any aetiological significance. In that latter case a hitherto unknown lack of wax decomposition during several decades has to be considered.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3659613

Source DB:  PubMed          Journal:  Sarcoidosis        ISSN: 0393-1447


  11 in total

1.  Familial idiopathic granulomatosis: sarcoidosis and Crohn's disease in two Indian families.

Authors:  P Bambery; U Kaur; S R Bhusnurmath; J B Dilawari
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

2.  Observations on the Kveim reaction using an animal model of granulomatous bowel disease.

Authors:  I C Mitchell; J L Turk
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

3.  Differentiation of sarcoidosis from tuberculosis by use of electron capture gas-liquid chromatography.

Authors:  P L Almenoff; J B Brooks; A Johnson; M Lesser
Journal:  Lung       Date:  1996       Impact factor: 2.584

4.  Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis.

Authors:  H M Fidler; G A Rook; N M Johnson; J McFadden
Journal:  BMJ       Date:  1993-02-27

Review 5.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 6.  Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders.

Authors:  G A W Rook; V Adams; J Hunt; R Palmer; R Martinelli; L Rosa Brunet
Journal:  Springer Semin Immunopathol       Date:  2003-10-08

Review 7.  Etiology of sarcoidosis: does infection play a role?

Authors:  Shiv Saidha; Elias S Sotirchos; Christopher Eckstein
Journal:  Yale J Biol Med       Date:  2012-03-29

Review 8.  Sarcoidosis: Immunopathogenesis and Immunological Markers.

Authors:  Wei Sheng Joshua Loke; Cristan Herbert; Paul S Thomas
Journal:  Int J Chronic Dis       Date:  2013-07-25

9.  Immunohistochemical Detection of Propionibacterium acnes in the Retinal Granulomas in Patients with Ocular Sarcoidosis.

Authors:  Kenji Nagata; Yoshinobu Eishi; Keisuke Uchida; Kazuhito Yoneda; Hiroki Hatanaka; Toru Yasuhara; Maho Nagata; Chie Sotozono; Shigeru Kinoshita
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

10.  Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.

Authors:  Zhimin Song; Lisa Marzilli; Brian M Greenlee; Edward S Chen; Richard F Silver; Frederic B Askin; Alvin S Teirstein; Ying Zhang; Robert J Cotter; David R Moller
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.